✨
Yapay Zeka Hızlı Bakış & Çıkarımlar
AI Insight⚡ TL;DR(1 Cümlede Hızlı Çıkarım)
Endothelin receptor antagonists, such as bosentan and ambrisentan, have been developed to treat PAH and other cardiovascular disorders, underscoring ET-1’s significance in disease mechanisms and treatment strategies
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Given its broad role in cardiovascular diseases, ET-1 and its receptors are therapeutic targets.
📊
Temel Bulgular & Veri:Given its broad role in cardiovascular diseases, ET-1 and its receptors are therapeutic targets.
💡
Sonuç & Katkı:Endothelin receptor antagonists, such as bosentan and ambrisentan, have been developed to treat PAH and other cardiovascular disorders, underscoring ET-1’s significance in disease mechanisms and treatment strategies
🔬Tür:Editöre Mektup
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Endothelin-1 · Gastrointestinal Bleeding · Endothelin-1
Abstract
Given its broad role in cardiovascular diseases, ET-1 and its receptors are therapeutic targets. Endothelin receptor antagonists, such as bosentan and ambrisentan, have been developed to treat PAH and other cardiovascular disorders, underscoring ET-1’s significance in disease mechanisms and treatment strategies
Anahtar kelimeler
🔖
Bu Makaleye Atıf Yap
Tütüncü, M. F., Onur, B., Demirbaş, H. B. (2024). Endothelin-1 and Gastrointestinal Bleeding: A Predictor for Clinical Outcomes. Eurasian Journal of Critical Care, Cilt: 6 Sayı: 3, 151–152. https://doi.org/10.55994/ejcc.1550651